Holocene Advisors, LP Intra Cellular Therapies, Inc. Transaction History

Holocene Advisors, LP

$29.2 Billion
Q4 2024

A detailed history of Holocene Advisors, LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 1,198,298 shares of ITCI stock, worth $154 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

1,198,298

Previous 1,370,831 12.59%

Holding current value

$154 Million

Previous $100 Million 0.15%

% of portfolio

0.34%

Previous 0.44%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$71.19 - $91.57 $12.3 Million - $15.8 Million	-172,533 Reduced 12.59%	1,198,298 $100 Million
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $7.4 Million - $8.8 Million	-108,844 Reduced 7.36%	1,370,831 $100 Million
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $37 Million - $45.6 Million	570,585 Added 62.76%	1,479,675 $101 Million
Q1 2024 May 15, 2024	SELL	$64.37 - $75.65 $22.7 Million - $26.7 Million	-352,767 Reduced 27.96%	909,090 $62.9 Million
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $7.91 Million - $12.6 Million	-170,659 Reduced 11.91%	1,261,857 $90.4 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $13.7 Million - $16.9 Million	-263,292 Reduced 15.53%	1,432,516 $74.6 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $31.7 Million - $38.5 Million	579,544 Added 51.92%	1,695,808 $107 Million
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $26.9 Million - $35 Million	-614,829 Reduced 35.52%	1,116,264 $60.4 Million
Q4 2022 Feb 14, 2023	BUY	$44.07 - $54.45 $6.16 Million - $7.61 Million	139,710 Added 8.78%	1,731,093 $91.6 Million
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $1.54 Million - $2.16 Million	-36,025 Reduced 2.21%	1,591,383 $74 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $38.9 Million - $59.4 Million	904,684 Added 125.18%	1,627,408 $92.9 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $28 Million - $44.9 Million	722,724 New	722,724 $44.2 Million

Others Institutions Holding ITCI

# of Institutions

416

Shares Held

88.5M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.1B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Account

Holocene Advisors, LP Intra Cellular Therapies, Inc. Transaction History